Pricing Log in Create free account

Aspira Women's Health Inc. (AWHL) vs iSpecimen Inc. (ISPC)

Aspira Women's Health Inc. and iSpecimen Inc. are both Diagnostics & Research companies. Aspira Women's Health Inc. is the larger, with a market value of $2.4M against $2.0M — 1.2× the size. Aspira Women's Health Inc. grew revenue faster over the last twelve months: −8.00% against −92.1%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −2,449.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Aspira Women's Health Inc. leads on 12 and iSpecimen Inc. on 4.

Valuation

Metric AWHL ISPC Diagnostics & Research median
P/E n/m n/m 34.52
P/S 0.98 2.39 4.24
P/B n/m 0.64 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.08 23.44
EV/Sales 1.16 (1.47) 5.18
Earnings yield (128.42%) (6,581.25%) (1.50%)
Free cash flow yield (56.24%) (973.26%) 0.00%

Profitability

Metric AWHL ISPC Diagnostics & Research median
Gross margin 58.78% (108.26%) 48.32%
Operating margin (80.75%) (2,020.05%) (5.68%)
Net margin (117.07%) (2,449.02%) (4.10%)
Free cash flow margin (55.32%) (1,866.61%) 0.00%
Return on equity 201.29% (968.44%) 0.00%
Return on assets (213.58%) (170.09%) (6.05%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AWHL ISPC Diagnostics & Research median
Revenue growth (TTM) (8.00%) (92.11%) 8.99%
EPS growth (last fiscal year) 60.22% 87.03% 20.36%
Revenue growth, 5-year CAGR 14.66% (25.10%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL ISPC Diagnostics & Research median
Debt to equity (0.27) 0.00 0.01
Current ratio 0.52 0.82 2.27
Net debt to EBITDA 0.00 0.95 0.68

Dividend

Metric AWHL ISPC Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric AWHL ISPC Diagnostics & Research median
Market cap 2.44m 2.03m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack